跳至主要内容
临床试验/NCT03440853
NCT03440853已完成不适用

Technology Assisted Stepped Collaborative Care Intervention (TASCCI) to Improve Patient-centered Outcomes in Hemodialysis Patients

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2018年3月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
2
主要终点
Change in pain from baseline to 12 weeks

研究概览

简要总结

This study evaluates a collaborative care intervention in reducing depression, fatigue and pain symptoms and improving health related quality of life in hemodialysis patients. Half of participants will receive the collaborative care intervention, while the other half will receive technology delivered health education information.

详细描述

End-stage renal disease patients on hemodialysis experience substantial symptom burden with fatigue, pain and depression among the most debilitating and existing as symptom clusters. These symptom clusters can exacerbate one another, and are independent and strong predictors of poor health-related quality of life in hemodialysis patients. This study will look at the effect of a 12 week stepped care intervention on changes in depression, pain or fatigue and health related quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Patient reported outcomes will be administered centrally by blinded interviewers using computer-assisted telephone interviewing (CATI).

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • undergoing thrice-weekly maintenance hemodialysis for > 3 months
  • English speaking
  • able to provide informed consent
  • no evidence of thought disorder, delusions or active suicidal ideation

排除标准

  • thought disorder, delusions or active suicidal ideation
  • active substance abuse
  • too ill or cognitively impaired to participate based on clinicians' judgment
  • anticipated life expectancy of less than 1 year
  • unable or unwilling to adhere to study protocol
  • participating in another clinical trial or taking an investigational drug
  • scheduled for living donor kidney transplant within next 6 months
  • relocating to another dialysis unit within 6 months

结局指标

主要结局

Change in pain from baseline to 12 weeks

时间窗: Baseline and Post 12 week intervention

Pain symptoms will be measured using the Brief Pain Inventory

Change in fatigue from baseline to 12 weeks

时间窗: Baseline and Post 12 week intervention

Fatigue symptoms will be measured using the FACIT-F

Change in depression from baseline to 12 weeks

时间窗: Baseline and Post 12 week intervention

Depressive symptoms will be measured using the Beck Depression Inventory-II

次要结局

  • Change in adherence to hemodialysis treatments(Baseline and Post 12 week intervention)
  • Change in adherence to medications(Baseline, 3 month, 6 month, 12 month)
  • Change in adherence to fluid restriction(Baseline, 3 month, 6 month, 12 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Manisha Jhamb

Associate Professor of Medicine

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验